BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 11352117)

  • 21. Review article: current management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Aliment Pharmacol Ther; 2005 Apr; 21(8):933-48. PubMed ID: 15813829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
    Mueller T; Bianchi L; Menges M
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):232-6. PubMed ID: 18301306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possible treatment modalities of primary sclerosing cholangitis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Dec; 146(49):2479-83. PubMed ID: 16398312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical and endoscopic therapy of primary sclerosing cholangitis.
    Weismüller TJ; Lankisch TO
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):741-52. PubMed ID: 22117639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholestatic liver diseases].
    Reichel C; Meier-Abt PJ
    Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary sclerosing cholangitis: diagnosis and management.
    Charatcharoenwitthaya P; Lindor KD
    Curr Gastroenterol Rep; 2006 Feb; 8(1):75-82. PubMed ID: 16510038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Lindor KD; Kowdley KV; Harrison ME;
    Am J Gastroenterol; 2015 May; 110(5):646-59; quiz 660. PubMed ID: 25869391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
    Layfield LJ; Cramer H
    Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis.
    Schimanski U; Stiehl A; Stremmel W; Theilmann L
    Endoscopy; 1996 May; 28(4):346-9. PubMed ID: 8813500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent primary sclerosing cholangitis: Clinical diagnosis and long-term management issues.
    Gordon F
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S73-5. PubMed ID: 17051565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary sclerosing cholangitis].
    Benhamou JP
    Rev Prat; 2000 Dec; 50(19):2146-9. PubMed ID: 11213459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New therapeutical indications of ursodeoxycholic acid.
    Copaci I; Micu L; Iliescu L; Voiculescu M
    Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.